INGN
InogenFNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
The bull case is that May 7, 2026 confirms management’s prior setup: Q1 roughly in line with the prior year, full-year revenue guidance of $366 million to $373 million intact, and another step toward better adjusted EBITDA. With the stock at $6.98 and market cap around $181 million, even a modestly cleaner execution story could matter.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -4.2.
What can break
Multiple leadership changes in late March and early April 2026 create transition risk even if they ultimately help execution.
Momentum
22
Value
37
Sentiment
55
Setup hits (3d)
— · Net —
AI TargetsBase $6.50 · Bull $10.00 · Bear $4.50
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net —
Target $12.67
Why
Momentum22 · Δ7d +8.3
Value37 · Δ7d +0.1
Sentiment55 · Δ7d -4.2
So what
Weak posture. Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
22
26% active weight
Current posture
7d trendFlat
Δ7d
+8.3
Δ21d
+4.8
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.1
Sentiment
55
34% active weight
Current posture
7d trendSoftening
Δ7d
-4.2
Δ21d
+3.4
Why this grade
Composite grade F. Momentum 22.0 / Value 36.5 / Sentiment 55.4
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$177.88M
Beta
1.80
Shares Out
27.07M
P/E (TTM) · Derived
-7.7
P/S (TTM)
0.52
P/FCF (TTM) · Derived
-17.52
Rev YoY
+3.4%
EPS YoY
+24.2%
Gross Margin
+50.9%
Op Margin
-9.3%
Net Debt
-$103.39M
Current Ratio
3.10
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology